Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (23800)	8/3/1998 6:47:00 AM
From: Henry Niman	Respond to of 32384

bob, You are correct about analysts mentioning their own stocks. However, in addition to self promotion, the Biotechs listed in the Barron's article all have products on the market. It's rather common for articles focusing on takeovers to focus on the larger Biotechs. LGND of course is a good example of pharmas tapping into their technology via alliances. LGND's partners (PFE, GLX, AGN, ABT, AHP, SBH, Sankyo, LLY) represent about 1/4 of the pharmas so in one sense, LGND has already taken them over :-).

To: bob zagorin who wrote (23800)	8/3/1998 7:34:00 AM
From: Hippieslayer	Read Replies (1) \| Respond to of 32384

What! Not Objective? By what means are you to determine whether or not I am objective? Because I don't agree with you or others in their near term price? What have I not been objective about? For your information, it was due to my objectivity that I got out of ligand. I had been in it for almost 2 years but saw that my money would be better suited in a stock that has a little bit more backbone thatn ligand. You must base your ideas on that stupid BOP program cuz not only have you been wrong with it in regards to ligand you're wrong with in everything else!. TO the lurkers out there, just read the corresponding post that I am answer of BOBs and then youll see the idiocy of some of the posters here. Its the sheer fact that there isn't very much objectivity here that is the reason why I and Tony post. One pertinent question to ask yourself: In the light of all the postive spin (and some of it happens to be valid) in which direction has the stock gone? How has it performed in relations to the rest of the market?